Immediate Outcomes of Aortic Valve Neocuspidization with Glutaraldehyde-treated Autologous Pericardium: a Multicenter Study

Arutyunyan, V. B.; Чернов, И. И.; Комаров, Р. Н.; Sinelnikov, Yuriy; Kadyraliev, Bakytbek; Энгиноев, С. Т.; Tcheglov, M. I.; Ismailbaev, Alisher; Баранов, А. П.; Ashurov, Fatali; Clavel, Marie‐Annick; Weymann, Alexander; Zhigalov, Konstantin

doi:10.21470/1678-9741-2020-0019

Cited by 13 publications

(12 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to the surgical data of our patients mean ACC time and CPB time were 118.1 ± 33.2 (min -max: 67 -173) minutes and 162 ± 45.7 (min -max: 97 -245) minutes respectively. Although these durations were longer than the durations of Arutyunyan et al, in their study the rate of patients who underwent isolated AVNeo was higher than the rate of patients in our study [19]. In our study, in patients who underwent isolated AVNeo procedure, mean ACC time and CPB time 93.3 ± 18.2 were 130.3 ± 31.6 minutes respectively.…”

Section: Discussioncontrasting

confidence: 75%

Aortic Neocuspidization with Autologous Pericardium: Initial Experience of Single Center

Karabacak¹,

Kubat²,

Erol³

et al. 2021

WJCS

View full text Add to dashboard Cite

Background: Aortic neo-cuspidization (AVNeo) procedure has been adopted by limited centers with the publication of the mid-long term successful results. The aim of this study was to present initial experience of the AVNeo procedure of a single center. Methods: The medical records of 24 patients who underwent AVNeo with or without concomitant cardiac surgery between February 2019 and February 2021 at our tertiary hospital were scanned retrospectively. Results: The mean age of patients was aged 58.21 ± 13.14 years and 16 (66.7%) of them were men. 16 patients were operated on for aortic stenosis (66.67%). Morphology of the aortic valve was tricuspid in 21 (87.5%) and bicuspid in 3 (12.5%) of the patients. Additional cardicac surgery was performed in 13 (54.17%) patients. No patients needed reoperation for bleeding, pacemaker implantations, conversion to classical prosthetic aortic valve replacement, or infective endocarditis. Two patients died due to non-cardiac reasons. Preoperative peak and mean aortic valve pressures improved significantly at 1 st and 6 th months (

show abstract

Section: Discussioncontrasting

confidence: 75%

Aortic Neocuspidization with Autologous Pericardium: Initial Experience of Single Center

Karabacak¹,

Kubat²,

Erol³

et al. 2021

WJCS

View full text Add to dashboard Cite

show abstract

“…(8) Similar results were reported by several other centres suggesting this procedure are reproducible across different centres and surgical teams. (9)(10)(11) Krane et al demonstrated the effectiveness of this technique in a younger population and compared the haemodynamic performance with virtually implanted Trifecta Bioprostheses. They reported a significantly lower mean pressure gradient as well as a higher mean effective orifice area in AV Neo.…”

Section: Clinical Outcome Of Av Neomentioning

confidence: 99%

Aortic Valve Neocuspidization using glutaraldehyde-treated autologous pericardium: A literature review

Chan

Basu

discenza

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Aortic Valve Neocuspidization using glutaraldehyde-treated autologous pericardium was first performed by Ozaki et al. in 2007. This technique has become an alternative to tissue and mechanical valve as long-term anticoagulation is not required and shows promising midterm results and durability. Method: A comprehensive search was performed on the major database using search terms “Ozaki technique” AND “Aortic Valve Neocuspidization” AND “AV Neocuspidization” AND “Autologous pericardium” AND “glutaraldehyde-treated autologous pericardium”. Articles up to 1st of August 2020 were included in this study. Results: A total of 9 studies with a total of 1342 patients were included. The mean age was 67.36 and 54.23% were male. 66.32% and 23.92% of patients had aortic stenosis and aortic regurgitation, respectively. 66% of patients had a native tricuspid aortic valve and 31.37 % patients’ native aortic valve was bicuspid. Three studies reported their experience performing Aortic Valve Neocuspidization via mini sternotomy. Conclusion: Aortic Valve Neocuspidization is an alternative to biological and mechanical prostheses for surgical aortic valve replacement. The short and mid-term outcome are comparable without the need for long term oral anticoagulation. Long term follow-up data is required for this novel approach to be widely adopted.

show abstract

“…Учитывая, что данная методика новая и не так много центров выполняют данную операцию, нами в 2019г был создан Российский регистр AVNeo по методике Ozaki для оценки непосредственных и отдаленных результатов. Были опубликованы наши первые непосредственные результаты 170 больных после AVNeo [3], чуть позже доложены результаты хирургического лечения больных с узким ФК АК с хорошими непосредственными результатами [4]. В этом исследовании мы хотим проанализировать непосредственные результаты регистра, выяснить, является ли AVNeo приемлемой и воспроизводимой методикой.…”

unclassified

Short-term outcomes of Ozaki procedure: a multicenter study

et al. 2021

View full text Add to dashboard Cite

Immediate Outcomes of Aortic Valve Neocuspidization with Glutaraldehyde-treated Autologous Pericardium: a Multicenter Study

Cited by 13 publications

References 18 publications

Aortic Neocuspidization with Autologous Pericardium: Initial Experience of Single Center

Aortic Neocuspidization with Autologous Pericardium: Initial Experience of Single Center

Aortic Valve Neocuspidization using glutaraldehyde-treated autologous pericardium: A literature review

Short-term outcomes of Ozaki procedure: a multicenter study

Contact Info

Product

Resources

About